معرفی
Dr. Sebastien Talbot is an Associate Professor at Queen's University's Department of Biomedical and Molecular Sciences, affiliated with the School of Medicine and Faculty of Health Sciences. His research focuses on neuro-immune interactions, particularly in host defense mechanisms and chronic inflammatory diseases. He holds a PhD in Neurobiology from Harvard Medical School (2017) and a BSc in Pharmacology from Université de Sherbrooke (2006).
Research interests include neuro-immune cross-talk in cancer, immune tolerance mechanisms, and the role of sensory neurons in immunological processes. His lab develops innovative therapies targeting neural-tumor microenvironment interactions and employs advanced bioprinting technologies (e.g., LIST laser-assisted cell printing). Key collaborations involve mesenchymal stromal cell engineering and immunoproteasome-based vaccines.
Recent work emphasizes neuro-immune pathways in cancer immunotherapy resistance, pain modulation in chronic diseases, and the interplay between nerves and tumor progression. Articles highlight discoveries in neurogenic inflammation, cytokine signaling, and neuronal circuits affecting immunity. No specific awards are listed, but his work is supported by grants and collaborations with institutions like the Queen's Laboratory for Molecular Pathology.
Laboratory activities include bioprinting technologies for neural and immune cell models, preclinical testing of novel therapeutics, and systems-level analysis of neuroimmune networks. Dr. Talbot maintains an active Google Scholar profile and lab website for further details.
